Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Non-Current Assets (2016 - 2020)

Historic Other Non-Current Assets for China Pharma Holdings (CPHI) over the last 8 years, with Q2 2020 value amounting to $222996.0.

  • China Pharma Holdings' Other Non-Current Assets fell 5569.43% to $222996.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $222996.0, marking a year-over-year decrease of 5569.43%. This contributed to the annual value of $109908.0 for FY2019, which is 9137.26% down from last year.
  • As of Q2 2020, China Pharma Holdings' Other Non-Current Assets stood at $222996.0, which was down 5569.43% from $331038.0 recorded in Q1 2020.
  • China Pharma Holdings' Other Non-Current Assets' 5-year high stood at $2.6 million during Q2 2017, with a 5-year trough of $109908.0 in Q4 2019.
  • Over the past 5 years, China Pharma Holdings' median Other Non-Current Assets value was $1.2 million (recorded in 2018), while the average stood at $1.1 million.
  • As far as peak fluctuations go, China Pharma Holdings' Other Non-Current Assets surged by 10492.49% in 2017, and later plummeted by 9137.26% in 2019.
  • China Pharma Holdings' Other Non-Current Assets (Quarter) stood at $1.1 million in 2016, then tumbled by 34.81% to $709796.0 in 2017, then soared by 79.48% to $1.3 million in 2018, then tumbled by 91.37% to $109908.0 in 2019, then surged by 102.89% to $222996.0 in 2020.
  • Its last three reported values are $222996.0 in Q2 2020, $331038.0 for Q1 2020, and $109908.0 during Q4 2019.